Publicaciones (27) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513

  2. A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight

    Contact Dermatitis, Vol. 91, Núm. 3, pp. 228-236

  3. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Contact Dermatitis, Vol. 91, Núm. 5, pp. 404-411

  4. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)

    Contact Dermatitis, Vol. 91, Núm. 5, pp. 379-386

  5. Cosmetovigilance for infrequent allergens in Spain using a national online registry: The example of allergic contact dermatitis caused by phenylethyl resorcinol

    Contact Dermatitis, Vol. 90, Núm. 3, pp. 245-252

  6. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 539-546

  7. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

  8. Extensive tinea corporis caused by Trichophyton indotineae: Report of a case in Spain

    Journal of the European Academy of Dermatology and Venereology

  9. Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 10-20

  10. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. 331-340

  11. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

    Experimental Dermatology, Vol. 33, Núm. 8

  12. Impact of inflammatory skin conditions on the biological profile of plasma rich in growth factor

    Tissue and Cell, Vol. 91

  13. Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional Study

    Actas Dermo-Sifiliograficas

  14. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

    Journal of the European Academy of Dermatology and Venereology

  15. Necrosis y ulceración en la zona pectoral: una presentación poco frecuente de un diagnóstico común

    Más dermatología, Núm. 46, pp. 22-23

  16. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

    Contact Dermatitis

  17. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019–2022 prospective study with cluster and network analysis

    Journal of the European Academy of Dermatology and Venereology

  18. Rapid response of erythrodermic pityriasis rubra pilaris to tildrakizumab

    Clinical and Experimental Dermatology

  19. Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial

    Actas Dermo-Sifiliograficas

  20. Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial Mucositis

    JAMA Dermatology, Vol. 160, Núm. 3, pp. 320-327